SU628923A1 - Medicine for arresting hypertensive crisis - Google Patents
Medicine for arresting hypertensive crisisInfo
- Publication number
- SU628923A1 SU628923A1 SU731955148A SU1955148A SU628923A1 SU 628923 A1 SU628923 A1 SU 628923A1 SU 731955148 A SU731955148 A SU 731955148A SU 1955148 A SU1955148 A SU 1955148A SU 628923 A1 SU628923 A1 SU 628923A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- medicine
- arresting
- droperidol
- hypertensive crisis
- hypertensive
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Изобретение относитс к медицине и касаетс лекарственного средства, которое может быть использовано дл купировани гипертонических кризов.This invention relates to medicine and relates to a drug that can be used to relieve hypertensive crises.
Известно применение аминазина дл купировани гипертонических кризов 1.Known use of aminazine for the relief of hypertensive crises 1.
Однако при внутривенном введении аминазина резко падает артериальное давление , возможно угнетение дыхани и кровообращени , а в отдельных случа х по вл ютс судороги.However, when aminazine is administered intravenously, blood pressure drops sharply, respiratory and circulatory depression is possible, and in some cases convulsions appear.
Дроперидол известен как препарат, обладаюш ,ий нейролептическим действием 2.Droperidol is known as a drug that has a neuroleptic effect 2.
Целью изобретени вл етс расширение ассортимента средств дл купировани гипертонических кризов.The aim of the invention is to expand the range of means for stopping hypertensive crises.
Это достигаетс применением дроперидола в качестве средства дл купировани гипертонических кризов.This is achieved by using droperidol as a means for stopping hypertensive crises.
2 мл стерильного 0,25%-ного раствора дроперидола (5 мг препарата) из флакона раствор ют до 20 мл физиологическим раствором или 5%-ным раствором глюкозы и ввод т внутривенно струйно медленно, контролиру самочувствие больного, величину артериального давлени и частоту пульса . Контроль за этими показател ми осуществл ют через каждые 10 мин в течение от 30 мин до 3 час.2 ml of sterile 0.25% solution of droperidol (5 mg of the drug) from the vial is dissolved to 20 ml with physiological saline or 5% glucose solution and injected slowly intravenously in a jet to control the patient's well-being, blood pressure and pulse rate. These indicators are monitored every 10 minutes for 30 minutes to 3 hours.
При введении 5 мг дроперидола у большинства больных уже через 10 мин наблюдают выраженное снижение артериального давлени , нормализацию частоты пульса, улучшение самочувстви (уменьшение или исчезновение головной боли, головокружени , беспокойства, тошноты, рвоты, дрожи в теле).With the introduction of 5 mg of droperidol, in most patients, after 10 minutes, a pronounced decrease in blood pressure, normalization of the pulse rate, and an improvement in health (decrease or disappearance of headache, dizziness, anxiety, nausea, vomiting, and tremors in the body) are observed.
Систолическое давление после введени дроперидола снижаетс на 30-100 мм рт. ст, а диастолическое давление на 10- 50 мм рт. ст.Systolic pressure after droperidol administration is reduced by 30-100 mm Hg. St, and the diastolic pressure at 10-50 mm Hg. Art.
Исследовани показали, что гипотензивный эффект был достаточным у 74% больных .Studies have shown that the hypotensive effect was sufficient in 74% of patients.
Препарат хорошо переноситс больными.The drug is well tolerated.
Дроперидол обеспечивает выраженный гипотензивный и седативный эффект, без избыточного снижени артериального давлени , нормализует частоту сердечных сокраш ,ений, улучшает самочувствие и высокий терапевтический эффект.Droperidol provides a pronounced hypotensive and sedative effect, without an excessive decrease in blood pressure, normalizes the frequency of cardiac contractility, improves health and a high therapeutic effect.
Дроперидол оказывает быстрый и выраженный гипотензивный эффект, купиру гипертонический криз.Droperidol has a fast and pronounced hypotensive effect, relieving hypertensive crisis.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU731955148A SU628923A1 (en) | 1973-08-08 | 1973-08-08 | Medicine for arresting hypertensive crisis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU731955148A SU628923A1 (en) | 1973-08-08 | 1973-08-08 | Medicine for arresting hypertensive crisis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU628923A1 true SU628923A1 (en) | 1978-10-25 |
Family
ID=20563341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU731955148A SU628923A1 (en) | 1973-08-08 | 1973-08-08 | Medicine for arresting hypertensive crisis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU628923A1 (en) |
-
1973
- 1973-08-08 SU SU731955148A patent/SU628923A1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kelly et al. | Thioridazine hydrochloride (Mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities | |
| Beecher | Pain in men wounded in battle | |
| Shulman et al. | A new treatment of barbiturate intoxication | |
| Snyder et al. | Reversal of amitriptyline intoxication by physostigmine | |
| Green et al. | Heart block in mianserin hydrochloride overdose. | |
| Bloom et al. | Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: A double-blind cross-over study with methyldopa. | |
| SU628923A1 (en) | Medicine for arresting hypertensive crisis | |
| Horton | The clinical use of histamine | |
| Spingarn et al. | Orthostatic circulatory insufficiency: its occurrence in tabes dorsalis and Addison's disease | |
| MILLS et al. | Treatment of hypertension with orally and parenterally administered purified extracts of veratrum viride: comparison with ganglionic (hexamethonium) and adrenergic blocking agents | |
| Hughes et al. | Parenteral reserpine in treatment of hypertensive emergencies | |
| Volpitto et al. | Electrocardiographic studies during anesthesia with intravenous barbiturates | |
| ROWNTREE et al. | EPHEDRIN THERAPY IN ADDISON’S DISEASE | |
| RU1831339C (en) | Agent to reduce pain syndrome during operation and at after-operational period | |
| Finnerty | Hypertensive crisis | |
| US4990513A (en) | Antihypoxic drug and method of its application | |
| ARONSON et al. | Paroxysmal hypertension simulating pheochromocytoma | |
| Furman et al. | Use of Cholinergic Drugs in Paroxysmal Supraventricular Tachycardia: Serious Untoward Reactions and Fatality from Treatment with Methacholine and Neostigmine | |
| RU2228762C1 (en) | Method for early therapy of gastrointestinal hemorrhages | |
| NEVINS | Anaphylactoid reaction following administration of one meprobamate tablet | |
| RU2069559C1 (en) | Method for performing sympathetic ganglionic block | |
| RU2258529C1 (en) | Method for early therapy of hemorrhagic shock of ii, iii degree | |
| SU1664323A1 (en) | Cardioprotector remedy "mildronate" | |
| RU2153871C2 (en) | Method of preparation of patients for coronarography | |
| Burch et al. | Congestive heart failure—acute pulmonary edema |